Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted mice.
Polanski AK, Ebner A, Ebner B, Hofmann A, Steinbronn N, Brandt A, Forkmann M, Tausche AK, Morawietz H, Strasser RH, Wunderlich C.
Polanski AK, et al. Among authors: ebner a, ebner b.
J Cardiovasc Pharmacol. 2013 Jun;61(6):545-52. doi: 10.1097/FJC.0b013e31828de47c.
J Cardiovasc Pharmacol. 2013.
PMID: 23474841